PLAT and atrial fibrillation: The rate of IV tPA use increased from 1.2% to 4.6% (p<0.001), DTN time ≤60 minutes improved from 7.1% to 50.8% (p<0.001), symptomatic hemorrhage after IV tPA decreased from 11.0% to 5.6% (p<0.001), anticoagulation treatment for AF increased from 32.1% to 64.1% (p<0.001), and lipid lowering drugs for LDL ≥100 mg/dL increased from 38.2% to 68% (p<0.001).